Latest Articles

iGlarLixi Enables Safe Ramadan Fasting for Most T2D Patients

Recommendations on treatment simplification of complex insulin regimens to improve clinical outcomes in patients with T2DM

Diabetes management during Ramadan

Closed-loop insulin delivery during exercise in people with T1DM

New 2022 ADA/EASD Guidelines: GLPP-1 RA/Insulin Combination Is Recommended

ADA/EASD recommend considering combination injectables therapy of basal insulin/GLP-1 RA (Such as Soliqua^®) as valuable treatment option to provide adequate efficacy for achieving and maintaining glycemic goals.

Post-exercise hypoglycemia in relation to medication regimen among adults with type 2 diabetes

Management of athletes and active people with diabetes - The American Medical Society for Sports Medicine (AMSSM) scientific statement

Lipid Management in Patients with Diabetes Mellitus

Cardiovascular diseases (CVDs) are the leading cause of death globally¹

According to the World Health Organization, an estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths¹. Of these deaths, 85% were due to myocardial infarction or stroke¹. A CV event is a highly traumatic experience for patients and their families². It takes a heavy emotional toll, brings widespread disability and significantly impedes quality of life^3,4.